RxSight (RXST) Cash from Investing Activities (2020 - 2026)

RxSight (RXST) has reported Cash from Investing Activities for 7 consecutive years, with $4.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Investing Activities fell 68.25% year-over-year to $4.7 million; the trailing twelve-month figure through Jun 2026 stood at -$5.1 million (down 118.57% YoY), and the FY2025 full-year result was $16.9 million, up 117.01% from the prior year.
• Cash from Investing Activities slipped to $4.7 million in Q2 2026 per RXST's latest filing, from $8.8 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $43.8 million in Q2 2022 and bottomed at -$115.6 million in Q2 2024.
• Historically, Cash from Investing Activities has averaged -$2.8 million across 5 years, with a median of $4.5 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities jumped 2984.82% in 2023, then sank 2731.29% in 2024.
• Over 5 years, Cash from Investing Activities stood at $10.4 million in 2022, then plunged by 56.12% to $4.6 million in 2023, then slumped by 71.09% to $1.3 million in 2024, then sank by 828.33% to -$9.6 million in 2025, then jumped by 148.39% to $4.7 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered $4.7 million, $8.8 million, and -$9.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.